Urology Clinical Trials in New York, NY

As of September 2026, 117 paid clinical trials are recruiting for Urology in New York, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

118 clinical trials for Urology

·Clear filters·

Email me when a new urology trial opens in New York, NY.

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

for Renal Cell Carcinoma

Sites in New York, Mineola +5 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18 - 120

Code: NCT07049926·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

for Advanced or Metastatic Adrenocortical Carcinoma

Sites in New York +2 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT07189403·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

for Prostate Cancer

Sites in New York +1 more location

Sponsor: Antelope Surgical Solutions, Inc

Sex: Male·Age: 18 - 90

Code: NCT06906471·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in New York +1 more location

Sponsor: GI Innovation, Inc.

Sex: All·Age: 18+

Code: NCT04977453·Phase 1, Phase 2·Recruiting·Listed Jul 2021

Apply to this trial

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

for Prostate Cancer

1 location in New York

Sponsor: SpectraCure AB

Sex: Male·Age: 18+

Code: NCT06807359·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

for Salivary Gland Tumor

Drug: AVA6000

Sites in New York +2 more locations

Sponsor: Avacta Life Sciences Ltd

Sex: All·Age: 18+

Code: NCT04969835·Phase 1·Recruiting·Listed Jul 2021

Apply to this trial

Comprehensive Assessment of Cancer Theranostic Response

for Prostate Cancer

Sites in New York +1 more location

Sponsor: AIQ Solutions

Sex: Male·Age: 18+

Code: NCT06815354·Recruiting·Listed Feb 2025

Apply to this trial

A Study of a Side Effects and Resource Navigation Program for People With Cancer

for Kidney Cancer

Sites in New York, Rockville Centre +6 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT07646847·Recruiting·Listed Jun 2026

Apply to this trial

A Study of Lower Dose Radiation Therapy for People With Prostate Cancer

for Prostate Cancer

Sites in New York, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male·Age: 18+

Code: NCT07635238·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

CUIMC Focal Therapy Registry

for Prostate Cancer

1 location in New York

Sponsor: Columbia University

Sex: Male·Age: 40 - 85

Code: NCT07623941·Recruiting·Listed Jun 2026

Apply to this trial

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

for Prostate Cancer

Sites in New York, Uniondale +6 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male·Age: All ages

Code: NCT07548164·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer

for Diffuse Pleural Mesothelioma

Sites in New York, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT07532902·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma

for Neuropathy

Sites in New York, Rockville Centre +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT07390617·Recruiting·Listed Feb 2026

Apply to this trial

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

for Biochemically Recurrent Prostate Carcinoma

Drug: Apalutamide

Sites in New York, Rego Park +276 more locations

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: Male·Age: 18+

Code: NCT04423211·Phase 3·Recruiting·Listed Jun 2020

Apply to this trial

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for Metastatic Renal Cell Carcinoma

Sites in New York, Uniondale +278 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT05327686·Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

for Anatomic Stage IV Breast Cancer AJCC v8

Sites in New York, Brooklyn +255 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06500455·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

for Breast Cancer

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT07225309·Recruiting·Listed Nov 2025

Apply to this trial

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for Prostate Adenocarcinoma

Sites in New York, Brooklyn +397 more locations

Sponsor: NRG Oncology

Sex: Male·Age: 18+

Code: NCT05946213·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound

for Prostate Cancer

1 location in New York

Sponsor: NYU Langone Health

Sex: Male·Age: 40 - 95

Code: NCT07184970·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Tarlatamab for People With Prostate Cancer

for Metastatic Prostate Cancer

Drug: Tarlatamab

Sites in New York, Uniondale +8 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male·Age: 18+

Code: NCT07111507·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation

for Prostate Cancer

Sites in New York & Brooklyn

Sponsor: NYU Langone Health

Sex: Male·Age: 40 - 95

Code: NCT07203482·Recruiting·Listed Oct 2025

Apply to this trial

Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer

for Prostate Cancer

1 location in New York

Sponsor: NYU Langone Health

Sex: Male·Age: 40 - 85

Code: NCT07184957·Recruiting·Listed Sep 2025

Apply to this trial

A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

for Prostate Cancer

Sites in New York, Rockville Centre +4 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT07335796·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Precision-Based Genomics in Prostate Cancer

for Prostate Cancer

Sites in New York +10 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Male·Age: 18 - 120

Code: NCT04706663·Recruiting·Listed Jan 2021

Apply to this trial

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

for Educational Materials for Genetic Testing

Sites in New York, Brooklyn +2 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT04751435·Recruiting·Listed Feb 2021

Apply to this trial

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

for Prostate Cancer

Sites in New York +2 more locations

Sponsor: Case Comprehensive Cancer Center

Sex: Male·Age: 18+

Code: NCT06150417·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

for Breast Cancer

Sites in New York, Uniondale +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06954337·Recruiting·Listed May 2025

Apply to this trial

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

for Androgen Axis Suppression

Drug: Apalutamide

Sites in New York +5 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: Male·Age: 18+

Code: NCT06274047·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

for Prostate Cancer

Drug: Relugolix

Sites in New York +3 more locations

Sponsor: Yale University

Sex: Male·Age: 18+

Code: NCT06111781·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

A Study of Surgical Techniques During Cystectomy

for Bladder Cancer

Sites in New York, Rockville Centre +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 21+

Code: NCT06703476·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Study of Mental Health Care in People With Cancer

for Breast Cancer

1 location in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 65+

Code: NCT06037954·Recruiting·Listed Sep 2023

Apply to this trial

Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance

for Prostatic Neoplasms

1 location in New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Male·Age: 18+

Code: NCT07285057·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for Prostate Cancer

Sites in New York, Brooklyn +33 more locations

Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male·Age: 21+

Code: NCT03151629·Recruiting·Listed May 2017

Apply to this trial

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

for Prostate Cancer

1 location in New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Male·Age: 18+

Code: NCT07027124·Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

for Prostate Cancer

Sites in New York, Uniondale +10 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male·Age: 18+

Code: NCT06457919·Phase 1, Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

for Metastatic Renal Cell Carcinoma

Drug: Cabozantinib

Sites in New York, Uniondale +6 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06835972·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer

for Urothelial Carcinoma

Sites in New York, Rockville Centre +5 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT05239624·Phase 2·Recruiting·Listed Feb 2022

Apply to this trial

Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer

for Prostate Cancer

Sites in New York & Brooklyn

Sponsor: Weill Medical College of Cornell University

Sex: Male·Age: 18 - 99

Code: NCT04886986·Phase 1·Recruiting·Listed May 2021

Apply to this trial

The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer

for Prostate Cancer

2 locations in New York

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male·Age: 18+

Code: NCT04167969·Phase 1·Recruiting·Listed Nov 2019

Apply to this trial

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

for Advanced Renal Cell Carcinoma

Sites in New York +3 more locations

Sponsor: Karie Runcie

Sex: All·Age: 18+

Code: NCT06863311·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Conditions in Urology (New York, NY)

Prostate cancer· 77 Bladder cancer· 27 Metastatic prostate cancer· 16 Kidney cancer· 16 Overactive bladder· 2